WO2016111478A1 - Whitening cosmetic composition containing inorganic ring as active ingredient - Google Patents

Whitening cosmetic composition containing inorganic ring as active ingredient Download PDF

Info

Publication number
WO2016111478A1
WO2016111478A1 PCT/KR2015/013618 KR2015013618W WO2016111478A1 WO 2016111478 A1 WO2016111478 A1 WO 2016111478A1 KR 2015013618 W KR2015013618 W KR 2015013618W WO 2016111478 A1 WO2016111478 A1 WO 2016111478A1
Authority
WO
WIPO (PCT)
Prior art keywords
cosmetic composition
lotion
skin
skin whitening
inorganic ring
Prior art date
Application number
PCT/KR2015/013618
Other languages
French (fr)
Korean (ko)
Inventor
윤석균
노윤화
김종광
문성준
Original Assignee
코스맥스 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 코스맥스 주식회사 filed Critical 코스맥스 주식회사
Publication of WO2016111478A1 publication Critical patent/WO2016111478A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216Solid or semisolid forms
    • A61K8/022Powders; Compacted Powders
    • A61K8/0225Granulated powders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin

Definitions

  • the present invention is made by the task number 10046945 under the support of the Ministry of Knowledge Economy of Korea, the research and management institution of the project is Korea Industrial Technology Promotion Institute, the research project name is "World cl ass 300 project R & D", the research project name is "K-Cosmet ic” Development of skin cell receptor regulation functional new material and development of optimal skin delivery technology containing it ", the leading institution is Cosmax, and the research period is 2013.09.01 ⁇ 2017.08.31.
  • the present invention relates to a whitening cosmetic composition containing an inorganic ring as an active ingredient, and more particularly to a whitening cosmetic composition containing an inorganic ring consisting of extracts of sulfuric acid, sesame oil and white peony.
  • the present invention relates to a mixed extract having a skin whitening function using a herbal material, and more particularly, to a mixed extract extracted by hydrothermal extraction by applying distilled water to an inorganic ring (sulphurum, sewage oil, white currant) as listed in ⁇ Consent Bogam>.
  • Inorganic ring is composed of extracts of Huangyan, Fructus and Earl of Peony, and in ⁇ Donggibogam>, it cures eczema (a symptom of diarrhea with black water or diarrhea with black water or reddish abdomen, not refreshing after bowel movement). It is recorded as a prescription.
  • eczema a symptom of diarrhea with black water or diarrhea with black water or reddish abdomen, not refreshing after bowel movement. It is recorded as a prescription.
  • the research on the anti-inflammatory material called inorganic anti-inflammatory research on the RAW 264.7 cells by In-hwan Kim has already been conducted.
  • previous studies have not known about the skin whitening effect of the inorganic ring, and thus, in this study, the skin whitening function of the inorganic ring revealed that it inhibits tyrosinase inhibition and melanin production in melanoma cells. .
  • Melanin is a pigment widely distributed in animals and plants. In humans, it determines the skin color and plays an important role in protecting the human body from harmful ultraviolet rays and free radicals (Jong Eon Chin et. Al,, 2006). ).
  • the melanin pigment is synthesized from L-tyrosine through several stages of oxidation reaction, and its biosynthesis mechanism is tyrosinase DHICA oxidase C tyrosinase related protein— 1, TRP-1), DOPAchrome tautomerase ( tyrosinase related protein I 2, TRP-2) and Catechol-0 0 methyl transferase (COMT) are involved (Arcoa P. et. al., 1993, Paval S.
  • tyrosinase oxidizes L-tyrosine and dopa (3,4-dihydroxyphenylalanine, DOPA) to produce dopa (D0PA) and dopaquinone (D0PA-quinone). Since most of the skin color and skin pigmentation are determined by the amount and distribution of melanin in keratinocytes, do not inhibit the activity of tyrosinase that promotes the synthesis of melanin or inhibit melanin formation to test the whitening effect of whitening materials. Whether or not it matters.
  • Hydroquinone preparation inhibits the production of melanin pigment by inhibiting the activity of tyrosinase that is active when melanin pigment is synthesized in melanocytes. At present it is the most powerful bleaching agent.
  • retinoids is a synthetic derivative of vitamin A is also used in acne treatment, etc. And because of the peeling effect by changing the activity of keratinocytes, it doubles the effect of other bleaching agents.
  • Kojic acid (Koj ic acid) is less bleaching effect than hydroquinone preparation.
  • the great advantage is that there is no irritation on the skin.
  • Vitamin C is a known fact that vitamin C is effective in whitening effect, skin regeneration effect, fine wrinkles removal. But vitamin C is very unstable. That's why very few vitamin C preparations work really well on your skin.
  • Melanin inhibitors include hydroquinone, hydroxyanisole, ascorbic acid derivatives, kojic acid, azeraic acid, Corticosteroids, retinoids, arbutin and the like, but there are difficulties in use due to problems such as safety and economics.
  • hydroxyanisole and hydroquinone have strong melanogenesis inhibitory activity and at the same time cause side effects such as causing denaturation or lethality of pigment cells and impairing the original function of the cells.
  • Kojisan has problems such as discoloration during use and instability of the substance itself. As described above, a lot of preparations for skin whitening to inhibit melanin have been developed, but the use thereof is limited due to the effect of impermeability, stability on the skin, and formulation, and it is currently that the effect is not maximized by a single product. It is true.
  • the rhubarb used in the present invention i3 ⁇ 4o / s chinensis or Copt is chinensis Franch var.brevisepala.T.
  • Fructus oi / s rutaecarpa or Evodia officinalis Dode) used in the present invention is an unripe fruit of the genus Fructaceae, which is an unripe fruit 0 £ Voi // a officinalis, E. rutaecarpa) ⁇ It is used to treat vomiting, headache, stomatitis, and toothache by controlling the circulation of the body.
  • Peony ( ⁇ 3 ⁇ 4 ⁇ , Paeonia Radix) used in the present invention is a perennial herb (/ 3 ⁇ 4 «? / A albiflora P. and Paeonia lacti flora P.) and crops of peonies and 03 ⁇ 4 «? / 7 / ce e / 3 ⁇ 4 «/ obovata M.).
  • Ingredients include paeoniflorin, paeonol, paeonine, tannin, benzoic acid, benzoic acid, essential oils, Resin, sugar, and the like.
  • oriental medicine it is used as a medicine for retrospectives, blood sedatives, sedatives, gynecology and surgery.
  • the perennial herb Peony (Paeonia lact if lora P.) was used.
  • the present inventors have made diligent research efforts to overcome the problems of the prior art, and as a result of investigating various natural products to develop a safe and effective cosmetic composition for skin whitening, the skin whitening containing the inorganic ring of the present invention as an active ingredient
  • the cosmetic composition for the tyrosinase inhibitory effect and melanin formation inhibitory effect was shown, and furthermore, the inorganic ring has a tyrosinase inhibitory effect than the extract of sulfur, sesame oil and baekryeok alone, the skin whitening effect was confirmed that And completed the present invention,
  • the main object of the present invention is to provide a natural herbal cosmetic composition for skin whitening containing an inorganic ring having an skin whitening effect as an active ingredient by exhibiting a tyrosinase inhibitory effect and a melanin formation inhibitory effect.
  • the present invention provides a cosmetic composition for skin whitening containing an inorganic ring as an active ingredient.
  • the inorganic ring is characterized in that consisting of extracts of rhubarb, sessile and earl.
  • the term "inorganic ring" of the present invention is composed of extracts of Huangyan, sorghum and Earl of Tooth, and ⁇ I agree Bogam> Wet the inorganic ring (swelling of the abdomen and bowel movements) It is recorded as a prescription to cure diarrhea, which is not clear afterwards, and diarrhea such as black water or diarrhea with black and red color.
  • the present inventors have conducted research to invent a cosmetic composition for safe and effective skin whitening, and as a result, the inorganic ring exhibits a tyrosinase inhibitory effect and a melanin formation inhibiting effect, thereby confirming the skin whitening effect, and to complete the present invention. It became.
  • the extract can be extracted with any solvent conventionally used, preferably distilled water, lower alcohol having 1 to 4 carbon atoms, butylene glycol, propylene glycol, glycerin or a mixed solvent thereof It is characterized in that, more preferably, hot water extraction for 1 to 4 hours at 80 ⁇ 90 ° C temperature in distilled water.
  • the extract is characterized in that it is contained in 0.0001 to 50% by weight relative to the total composition.
  • 0.0001% by weight or less of the range may not be a clear whitening effect, when it exceeds 50.0 by weight 3 ⁇ 4 there may be no obvious whitening effect increase due to the increase of the content, there is a safety problem or difficulty in preparation of the formulation There may be.
  • the composition has a skin whitening effect by inhibiting tyrosinase activity and inhibiting melanin biosynthesis.
  • the inorganic ring of the present invention in the case of the inorganic ring of the present invention, it was confirmed that the inhibition of tyrosinase and the formation of melanin, and more excellent in the tyrosinase inhibitory effect than the extracts of sulfur, sesame and peony alone. I could confirm that.
  • the inorganic ring of the present invention effectively inhibits tyrosinase and effectively inhibits melanin production. It can be seen that it is suitable as a cosmetic composition (see Experimental Examples 1 to 5).
  • the composition is a skin lotion, skin softener, skin toner, astringent, lotion, milk lotion, moisturizing lotion, nutrition lotion, masseur cream, nutrition cream, moisture cream, hand cream, foundation, essence, nutrition essence, Pack, soap, cleansing product, cleansing lotion, cleansing cream, body lotion and body cleanser characterized in that it has one formulation selected from the group consisting of.
  • composition of the present invention may include other auxiliaries in addition to the carrier, for example i: cotton preservatives, antioxidants, stabilizers, solubilizers, vitamins, pigments and flavorings and the like.
  • the inorganic ring of the present invention exhibits a skin whitening effect by inhibiting tyrosinase inhibition and melanin formation, and thus is suitable as a natural herbal cosmetic composition for skin whitening.
  • FIG. 1 is a graph showing the result of the melanin production inhibitory effect of the inorganic ring.
  • Figure 2 is a graph showing the results for cytotoxicity of inorganic rings.
  • Figure 3 is a graph showing the results for the inorganic ring tyrosinase gene expression.
  • the inorganic ring material, yellow rye, sewage oil, and white peony were added to a grinder in a ratio of 1: 1, respectively, to prepare a mixed powder of 100 g, and then put into a water bath with distilled water 1000 and extracted with hot water. After extracting the hot water for 2 to 3 hours, the extract was filtered under reduced pressure with a Waterman filter paper, and then, the remaining extract was concentrated in a vacuum rotary distillation apparatus with a condenser to obtain a dry weight of 16.7 g.
  • Experimental Example 1 Melanin production inhibition experiment using melanoma cells
  • Melanoma cells of B16F10 mice were cultured under defined conditions.
  • the evaluation method is as follows. Melanoma cells were suspended in DMEM containing 10% FBS and inoculated in 6-wel l piate with lxlO 5 cel ls per wel l and incubated until adhered to the wel l bottom. To induce melanin production, O. luM a -MSH was treated, and then the samples were incubated for 3 days after the ' concentration was added.
  • the concentration range of the inorganic ring extract was set to 10 / ig / i, 25 / g /, 50 / ig / m.
  • Arbutin 100 / zg / m was treated as a positive control of the melanin production ability experiment.
  • the cultured cells were washed with phosphate buffered salin (PBS) and recovered with trypsin.
  • the recovered cells were counted by a hematocytometer and collected in each treatment group so as to have the same cell number as lxlO 6 cel ls / mL, followed by centrifugation for 10 minutes at 10 rpm to obtain only cells.
  • the recovered cells were dried at 60 ° C. for 1 hour, and then 1M NaOH solution containing 10% DMS0 was added to obtain intracellular melanin.
  • the melanin solution was measured for absorbance at 490 nm using a microplate reader to evaluate the inhibition of melanin production.
  • Melanoma cells of B16F10 mice were cultured under defined conditions. The evaluation method is as follows. Melanoma cells were suspended in DMEM containing 10% FBS per wel l Inoculate the 96-well plate with lxlO 4 cells and incubate until attached to the bottom of the well. Remove the medium, and add the inorganic ring extract distilled at concentrations of 0.1 / g / m £, 0.5 / g / i, 1 g / mi, 5 ug / mi, 10 fig / id, 50 ug / ml and 100 A Treated and incubated at 5% CO 2 , 37 ° C. for 24 hours.
  • MTT 3- (4,5-dimetylthiazol-2-yl) 2,5-diphenyltetrazoliuni bromide
  • Melanoma cells of B16F10 mice were cultured under defined conditions.
  • the evaluation method is as follows. Melanoma cells are suspended in DMEM containing 10% FBS and inoculated in 6-well plates with lxlO 5 cells per well and incubated until attached to the bottom of the well. To induce melanin production, treatment with O.luM ⁇ -MSH, and then take the sample. Incubated for 24 hours after addition by concentration. The concentration of the inorganic ring extract was treated with the inorganic ring extract diluted to 0.1 ug / mi, 0.5 Mg / mi, 1 ug / ml, 5 ug / mi, 10 ⁇ / mi and 50 g / i.
  • Positive controls were treated with arbutin 100 / g / i.
  • the cultured cells were washed with phosphate buffered saline and 1 ra trizol was collected. 1/5 ratio of 0.2 Chloroform Triz) was added and voltexed to obtain a supernatant by centrifugation at 14000 rpm for 15 minutes at 4 ° C.
  • 0.5 mt isopropanol was added to the supernatant and reacted for 10 minutes, followed by centrifugation at 14000 rpm for 15 minutes to obtain a precipitate.
  • RNA dissolved in DEPC was quantified and cDNA was synthesized using the same amount of RNA per group.
  • SYBR GREEN master mix a cyanine dye, as a target for synthesized cDNA Real-time polymerase chain reaction (PCR) was performed to evaluate the gene expression level of tyrosinase. The results are shown in Table 1 below.
  • the experimental method is the same as that of ⁇ Experiment 3>.
  • the concentration of the inorganic ring extract was treated with 1 / ig / and the synergistic effects of the whitening effect of the inorganic ring were compared by the concentrations of 1, g / i of gold, earl pear and sewage induction.
  • Positive controls were treated with arbutin 100 g / m £. The results are shown in Table 2 and FIG.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a cosmetic composition for skin whitening containing, as an active ingredient, an inorganic ring consisting of goldthread, evodia and white peony extracts. According to the present invention, it is possible to exhibit a skin whitening effect by retarding tyrosinase and inhibiting the formation of melanin in the case of a cosmetic composition containing an inorganic ring as an active ingredient.

Description

【명세서】  【Specification】
[발명의 명칭】 [Name of invention]
무기환을 유효성분으로 함유하는 미백용화장료 조성물 [기술분야】  Cosmetic composition for whitening containing inorganic ring as active ingredient
본 발명은 대한민국 지식경제부 지원하에 과제번호 10046945에 의해 이루어진 것으로서, 상기 과제의 연구관리전문기관은 한국산업기술진홍원, 연구사업명은 "Wor ld cl ass 300 프로젝트 R&D" , 연구과제명은 "K-Cosmet i c 선도형 기능성 화장품용 피부세포 수용체 조절 기능성 신소재 발굴 및 이를 함유한 최적 피부전달기술 개발" , 주관기관은 코스맥스 (주), 연구기간은 2013.09.01 ~ 2017.08.31이다.  The present invention is made by the task number 10046945 under the support of the Ministry of Knowledge Economy of Korea, the research and management institution of the project is Korea Industrial Technology Promotion Institute, the research project name is "World cl ass 300 project R & D", the research project name is "K-Cosmet ic" Development of skin cell receptor regulation functional new material and development of optimal skin delivery technology containing it ", the leading institution is Cosmax, and the research period is 2013.09.01 ~ 2017.08.31.
본 발명은 무기환올 유효성분으로 함유하는 미백용 화장료 조성물에 관한 것으로, 더욱 구체적으로 황련, 오수유 및 백작약의 추출물로 구성된 무기환을 함유하는 미백용 화장료 조성물에 관한 것이다.  The present invention relates to a whitening cosmetic composition containing an inorganic ring as an active ingredient, and more particularly to a whitening cosmetic composition containing an inorganic ring consisting of extracts of sulfuric acid, sesame oil and white peony.
【배경기술】 Background Art
본 발명은 한방소재를 이용하여 피부 미백 기능을 가진 흔합추출물에 관한 것으로, 더욱 상세하게는 <동의보감>에 수록된 무기환 (황련, 오수유, 백작약)을 증류수를 적용하여 열수 추출한 흔합추출물에 관한 것이다.  The present invention relates to a mixed extract having a skin whitening function using a herbal material, and more particularly, to a mixed extract extracted by hydrothermal extraction by applying distilled water to an inorganic ring (sulphurum, sewage oil, white currant) as listed in <Consent Bogam>.
무기환은 황련, 오수유, 백작약의 추출물로 구성 되어 있으며 <동의보감>에서는 습리 (복부가 부풀어 오르고 배변 후에도 개운하지 않고, 검은색 물같은 설사, 혹은 검은색과 적색이 섞여있는 설사를 하는 증세)를 치료하는 처방으로 기록되어 있다. 또한, 김일현 등이 연구한 무기환 (戊己丸)의 RAW 264.7 세포에 대한 항염증작용 연구라는 항염증 소재로의 연구는 기존에 이미 진행되어 왔다. 그러나, 기존의 연구에서는 무기환의 피부 미백 효과에 대해서는 알려진바 없으며 이에, 본 연구에서 무기환의 피부 미백 기능을 연구한 결과, 타이로시나제 억제 작용 및 멜라노마 세포의 멜라닌 생성을 억제함을 알게 되었다. 멜라닌은 동물, 식물 등에 널리 분포하는 색소로서 사람의 경우 피부색을 결정하는 동시에 유해한 자외선이나 자유 라디칼 ( free radical )로부터 인체를 보호하는 증요한 역할을 담당하고 있다 (Jong Eon Chin et . al, , 2006) . 멜라닌 색소는 여러 단계의 산화반웅을 거쳐 L-티로신 (L-tyrosine)으로부터 합성되어지며, 이것의 생합성 기작에는 티로시나아제 (tyrosinase) DHICA oxidaseC tyrosinase related protein— 1, TRP-1) , DOPAchrome tautomerase( tyrosinase related protein一 2, TRP-2) , Catechol— 0一 methyl transferase(COMT)와 같은 여러 효소들이 관여하고 있다 (Arcoa P. et . al . , 1993 , Paval S. et . al . , 1993 , J imenez Cervants et . al . , 1994) . 이 중 티로시나아제 (tyrosinase)는 Lᅳ티로신 (L-tyrosine)과 도파 (3,4- dihydroxyphenylalanine ,DOPA)를 산화시켜 도파 (D0PA)와 도파퀴논 (D0PA- quinone)을 생성한다. 각질형성세포에 있는 멜라닌의 양과 분포에 의해 피부색 및 피부 색소 침착의 대부분이 결정되므로, 미백소재의 미백효과를 검정하기 위해서는 멜라닌의 합성을 촉진 시키는 티로시나아제의 활성을 저해 하거나 멜라닌 형성을 억제하는지 여부가 중요하다. Inorganic ring is composed of extracts of Huangyan, Fructus and Earl of Peony, and in <Donggibogam>, it cures eczema (a symptom of diarrhea with black water or diarrhea with black water or reddish abdomen, not refreshing after bowel movement). It is recorded as a prescription. In addition, the research on the anti-inflammatory material called inorganic anti-inflammatory research on the RAW 264.7 cells by In-hwan Kim has already been conducted. However, previous studies have not known about the skin whitening effect of the inorganic ring, and thus, in this study, the skin whitening function of the inorganic ring revealed that it inhibits tyrosinase inhibition and melanin production in melanoma cells. . Melanin is a pigment widely distributed in animals and plants. In humans, it determines the skin color and plays an important role in protecting the human body from harmful ultraviolet rays and free radicals (Jong Eon Chin et. Al,, 2006). ). The melanin pigment is synthesized from L-tyrosine through several stages of oxidation reaction, and its biosynthesis mechanism is tyrosinase DHICA oxidase C tyrosinase related protein— 1, TRP-1), DOPAchrome tautomerase ( tyrosinase related protein I 2, TRP-2) and Catechol-0 0 methyl transferase (COMT) are involved (Arcoa P. et. al., 1993, Paval S. et. al., 1993, J imenez Cervants et. al., 1994). Among these, tyrosinase oxidizes L-tyrosine and dopa (3,4-dihydroxyphenylalanine, DOPA) to produce dopa (D0PA) and dopaquinone (D0PA-quinone). Since most of the skin color and skin pigmentation are determined by the amount and distribution of melanin in keratinocytes, do not inhibit the activity of tyrosinase that promotes the synthesis of melanin or inhibit melanin formation to test the whitening effect of whitening materials. Whether or not it matters.
현재 사용되고 있는 멜라닌 저해제를 간단하게 예를 들자면,  To give a simple example of the melanin inhibitor currently in use,
①하이드로퀴논 제제 (Hydroquinone)로서 멜라닌 세포에서 멜라닌 색소가 합성될 때 활동하는 타이로시나제 (tyrosinase)의 활성을 억제하여 멜라닌 색소의 생성을 막는다. 현재로서는 가장 강력한 탈색제이다.  ① Hydroquinone preparation (Hydroquinone) inhibits the production of melanin pigment by inhibiting the activity of tyrosinase that is active when melanin pigment is synthesized in melanocytes. At present it is the most powerful bleaching agent.
②레티노이드 (ret inoid)는 비타민 A의 합성유도체로 여드름 치료 등에도 이용되고 있으며 각질형성세포의 활동을 변화시켜서 필링효과가 있기 때문에 다른 탈색제의 효과를 배가시킨다.  ② retinoids (ret inoid) is a synthetic derivative of vitamin A is also used in acne treatment, etc. And because of the peeling effect by changing the activity of keratinocytes, it doubles the effect of other bleaching agents.
③ 코직산 (Koj ic acid)은 하이드로퀴논 제제보다는 탈색효과가 약하지만. 피부에 전혀 자극이 없다는 게 큰 장점이다.  ③ Kojic acid (Koj ic acid) is less bleaching effect than hydroquinone preparation. The great advantage is that there is no irritation on the skin.
④ 비타민 C는 비타민 C가 미백효과와 피부재생 효과, 잔주름제거등에 효과가 있다는 것은 예전부터 알려진 사실이다. 하지만 비타민 C는 매우 불안정한 상태이다. 그렇기 때문에 피부에 정말로 잘 흡수되어 효과를 나타내는 비타민 C제제는 극히 드물다. 이렇게 멜라닌 저해제로는 하이드로퀴논, 하이드록시아니솔, 아스코르빈산 유도체, 코지산, 아제라익산, 코로티코스테로이드, 레티노이드, 알부틴 등이 있으나, 안전성과 경제성 등의 문제점으로 사용에 있어서 어려움이 있다. 특히, 하이드록시아니솔 및 하이드로퀴논 등은 강력한 멜라닌 생성 저해활성은 있으나ᅳ 동시에 색소세포의 변성 또는 치사를 유발하고 세포 본래의 기능을 손상시키는 등의 부작용을 나타낸다. 그리고 코지산은 사용 중의 변색, 물질자체의 불안전성 등의 문제점이 있다. 이와 같이 멜라닌을 억제 하는 피부미백용 제제가 많이 개발되어 있으나, 효과의 불층분성, 피부에 대한 안정성, 제형 등으로 인해 그 사용이 제한되고 있는 실정이며, 단일물로는 그 효과가 극대화되지 않는다는 것이 현 실정이다. 본 발명에서 이용되는 황련 (i¾o /s chinensis or Copt is chinensis Franch var. brevisepala . T. Wang et 은 쌍떡잎식물 미나리아재비목 미나리아재비과의 상록 여러해살이풀로 중국 원산이며 생약용으로 한국ᅳ일본ᅳ중국 등지에서 재배하기도 한다. 산지의 수림 그늘의 습진 땅에서 자란다. 땅속줄기는 굵고 옆으로 뻗으며 많은 수염뿌리가 나고 줄기 끝에 뿌리잎 4~5개가 난다. 줄기와 땅속줄기의 단면이 질은 황색인데서 붙여진 이름이다. 한방에서는 황련 ᅳ 왜황련의 뿌리를 채취하여 햇볕에 말린 것을 황련 (黄連)이라 하며, 건위 ·진정 ·소염 ·항균 등의 효능이 있어 소화 불량 ·복통 ·구토ᅳ이질 심계 (心淨) ·번열 (煩熱)ᅳ정신불안 ·인후종통 (咽喉腫痛 ) ·토혈 ·코피ᅳ하혈 등의 치료에 처방한다. ④ Vitamin C is a known fact that vitamin C is effective in whitening effect, skin regeneration effect, fine wrinkles removal. But vitamin C is very unstable. That's why very few vitamin C preparations work really well on your skin. Melanin inhibitors include hydroquinone, hydroxyanisole, ascorbic acid derivatives, kojic acid, azeraic acid, Corticosteroids, retinoids, arbutin and the like, but there are difficulties in use due to problems such as safety and economics. In particular, hydroxyanisole and hydroquinone have strong melanogenesis inhibitory activity and at the same time cause side effects such as causing denaturation or lethality of pigment cells and impairing the original function of the cells. Kojisan has problems such as discoloration during use and instability of the substance itself. As described above, a lot of preparations for skin whitening to inhibit melanin have been developed, but the use thereof is limited due to the effect of impermeability, stability on the skin, and formulation, and it is currently that the effect is not maximized by a single product. It is true. The rhubarb used in the present invention (i¾o / s chinensis or Copt is chinensis Franch var.brevisepala.T. Wang et is an evergreen perennial herb of the dicotyledonous plant of the genus Amanaceae It grows on eczema in the shade of forests in mountainous areas, the trunk is thick and extends to the side, with many beard roots, 4 ~ 5 root leaves at the end of stems. is named after. the barberry root herbal eu why because by taking the roots of barberry root that dried barberry root (黄連) in the sun, and stomach-soothing, got indigestion, abdominal pain, vomiting eu heterogeneous effects, such as anti-inflammatory, antibacterial simgye ( Prescription for the treatment of heart, heat and dysmenorrhea, sore throat pain, bleeding, and nosebleeds.
본 발명에서 이용되는 오수유 oi/s rutaecarpa or Evodia officinalis Dode)는 산초나무과 식물인 오수유나무 0£Voi//a officinalis, E. rutaecarpa)^ 성숙되지 않은 열매로서 한방에서는 위를 따뜻하게 하고 통증을 멎게 하며 기의 순환을 조절하여 구토, 두통, 구내염, 치통 등을 치료하는데 사용된다.  Fructus oi / s rutaecarpa or Evodia officinalis Dode) used in the present invention is an unripe fruit of the genus Fructaceae, which is an unripe fruit 0 £ Voi // a officinalis, E. rutaecarpa) ^ It is used to treat vomiting, headache, stomatitis, and toothache by controlling the circulation of the body.
본 발명에서 이용되는 백작약 (白 ¾藥, Paeonia Radix)은 모란과 0¾«?/7/ ce e)의 다년생초인 작약 (/¾« ?/a albiflora P. 및 Paeonia lacti flora P.) 및 산작약 (/¾« / obovata M.)의 뿌리이다. 35속 1,500종이 있고 전 세계에 걸쳐 분포하지만 주로 북반구의 온대와 아한대인 한국, 일본, 중국, 사할린섬 등지에 분포하며 한국에는 21속 106종이 자라고 있다. 성분으로는 파이오이플로린 (paeoniflorin), 파이오놀 (paeonol ) , 파이오닌 (paeonine), 탄닌 (tannin), 벤조산 (benzoic acid), 안식향산, 정유, 수지, 당 등을 함유한다. 한방에서는 회고, 보혈제, 진정제, 부인과 ·외과 (外科)의 약재로 쓰인다. 본 발명에서는 다년생초인 작약 (Paeonia lact i f lora P. )을 사용 하였다. Peony (白 ¾ 白, Paeonia Radix) used in the present invention is a perennial herb (/ ¾ «? / A albiflora P. and Paeonia lacti flora P.) and crops of peonies and 0¾«? / 7 / ce e / ¾ «/ obovata M.). There are 1,500 species of 35 genera and distributed all over the world, but mainly in the temperate and boreal regions of the Northern Hemisphere, Korea, Japan, China, and Sakhalin Island. Ingredients include paeoniflorin, paeonol, paeonine, tannin, benzoic acid, benzoic acid, essential oils, Resin, sugar, and the like. In oriental medicine, it is used as a medicine for retrospectives, blood sedatives, sedatives, gynecology and surgery. In the present invention, the perennial herb Peony (Paeonia lact if lora P.) was used.
황련, 오수유 및 백작약은 상기에 기재한 효과만이 알려져 있으며, 종래 특허에서도 황련, 오수유 및 백작약 추출물인 무기환을 함유하는 피부 미백용 화장료 조성물에 대해서는 전혀 가재하고 있지 않다. 이에, 본 발명자들은 상기 무기환의 피부 미백 기능을 연구하였으며, 그 결과 무기환이 타이로시나제 저해 작용 및 멜라노마 세포의 멜라닌 생성을 억제하는 것을 확인하였다.  Only the effects described above are known in Huang Lian, Shou Yu and Baek Luk, and even in the prior patents, there is no crawfish for the cosmetic composition for skin whitening containing inorganic ring which is extract of Hwang Ryun, Osu Yu and Baekkuk. Accordingly, the present inventors studied the skin whitening function of the inorganic ring, and as a result, the inorganic ring inhibited tyrosinase inhibitory action and melanoma production of melanoma cells.
이에, 본 발명자들은 상기 종래기술들의 문제점들을 극복하기 위하여 예의 연구노력한 결과, 안전하고 효과적인 피부 미백용 화장료 조성물을 개발하기 위하여 여러 천연물을 조사한 결과, 본원발명의 무기환을 유효성분으로 함유하는 피부 미백용 화장료 조성물의 경우, 티로시나아제 저해 효과 및 멜라닌의 형성 억제 효과를 나타내었으며 더욱이, 무기환이 황련, 오수유 및 백작약 단독 추출물보다 뛰어난 티로시나아제 억제 효과를 나타냄으로써 피부 미백효과를 나타낼 수 있음을 확인하고, 본 발명을 완성하게 되었다,  Accordingly, the present inventors have made diligent research efforts to overcome the problems of the prior art, and as a result of investigating various natural products to develop a safe and effective cosmetic composition for skin whitening, the skin whitening containing the inorganic ring of the present invention as an active ingredient In the case of the cosmetic composition for the tyrosinase inhibitory effect and melanin formation inhibitory effect was shown, and furthermore, the inorganic ring has a tyrosinase inhibitory effect than the extract of sulfur, sesame oil and baekryeok alone, the skin whitening effect was confirmed that And completed the present invention,
【발명의 상세한 설명】 [Detailed Description of the Invention]
【기술적 과제】 따라서, 본 발명의 주된 목적은 티로시나아제 저해 효과 및 멜라닌의 형성 억제 효과를 나타냄으로써 피부 미백 효과를 갖는 무기환을 유효성분으로 함유하는 피부 미백용 천연 한방 화장료 조성물을 제공하는 데 있다.  Accordingly, the main object of the present invention is to provide a natural herbal cosmetic composition for skin whitening containing an inorganic ring having an skin whitening effect as an active ingredient by exhibiting a tyrosinase inhibitory effect and a melanin formation inhibitory effect. have.
【기술적 해결방법】 Technical Solution
본 발명의 한 양태에 따르면, 본 발명은 무기환을 유효성분으로 함유하는 피부 미백용 화장료 조성물을 제공한다.  According to one aspect of the present invention, the present invention provides a cosmetic composition for skin whitening containing an inorganic ring as an active ingredient.
또한, 본 발명에 있어서, 상기 무기환은 황련, 오수유 및 백작약의 추출물로 구성된 것을 특징으로 한다.  In addition, in the present invention, the inorganic ring is characterized in that consisting of extracts of rhubarb, sessile and earl.
본원발명의 상기 용어 "무기환" 이란, 황련, 오수유 및 백작약 추출물로 구성된 것으로, <동의보감>에는 무기환을 습리 (복부가 부풀어 오르고 배변 후에도 개운하지 않고, 검은색 물같은 설사, 혹은 검은색과 적색이 석여있는 설사를 하는 증세)를 치료하는 처방으로 기록되어 있다. 본 발명자들은 안전하고 효과적인 피부 미백용 화장료 조성물을 발명하기 위하여 연구노력한 결과, 상기 무기환이 티로시나아제 저해효과 및 멜라닌의 형성 억제 효과를 나타냄으로써 피부 미백 효과를 나타냄을 확인하고, 본 발명을 완성하게 되었다. The term "inorganic ring" of the present invention is composed of extracts of Huangyan, sorghum and Earl of Tooth, and <I agree Bogam> Wet the inorganic ring (swelling of the abdomen and bowel movements) It is recorded as a prescription to cure diarrhea, which is not clear afterwards, and diarrhea such as black water or diarrhea with black and red color. The present inventors have conducted research to invent a cosmetic composition for safe and effective skin whitening, and as a result, the inorganic ring exhibits a tyrosinase inhibitory effect and a melanin formation inhibiting effect, thereby confirming the skin whitening effect, and to complete the present invention. It became.
본 발명에 있어서, 상기 추출물은 종래에 사용 되어진 어떠한 용매로도 추출될 수 있으며, 바람직하게는 증류수, 탄소수 1 내지 4의 저급알코올, 부틸렌글리콜, 프로필렌글리콜, 글리세린 또는 이들의 흔합용매로 추출하는 것을 특징으로 하며,더욱 바람직하게는 증류수에서 80~90°C 온도로 1~4시간동안 열수 추출하는 것을 특징으로 한다. In the present invention, the extract can be extracted with any solvent conventionally used, preferably distilled water, lower alcohol having 1 to 4 carbon atoms, butylene glycol, propylene glycol, glycerin or a mixed solvent thereof It is characterized in that, more preferably, hot water extraction for 1 to 4 hours at 80 ~ 90 ° C temperature in distilled water.
본 발명에 있어서, 상기 흔합 추출물은 종래에 사용되어진 어떠한 추출방법으로 추출할 수 있으며, 바람직하게는 황련, 오수유 및 백작약의 분말을 증류수로 열수 추출하는 것을 특징으로 한다. 추출용매를 이용한 추출방법으로는 통상적인 식물의 추출방법 예를 들면, 열수 추출, 환류냉각 추출, 초음파 추출, 초임계 추출 등의 방법을 사용할 수 있다. 게다가, 상기 무기환은 황련, 오수유 및 백작약 단독 추출물을 각각 추출한 후 흔합한 추출물일 수도 있고 또는 황련, 오수유 및 백작약의 등중량 파쇄 흔합물에 대한 추출물일 수 있다.  In the present invention, the mixed extract can be extracted by any extraction method used in the prior art, preferably characterized in that the hot-water extraction of the powder of sulfuric acid, sewage oil and white currant with distilled water. As an extraction method using an extraction solvent, conventional extraction methods of plants, for example, hot water extraction, reflux cooling extraction, ultrasonic extraction, supercritical extraction and the like can be used. In addition, the inorganic ring may be a mixed extract after extracting the extracts of Huang lian, sessile and Baekjak respectively, or may be an extract for the isocratic mixture of hull, sesame and Baekjak.
본 발명에 있어서, 상기 추출물은 총 조성물에 대하여 0.0001 내지 50 중량 %로 함유되는 것을 특징으로 한다. 상기 범위인 0.0001 중량 % 이하의 경우에는 뚜렷한 미백 효과가 잘 나타나지 않을 수 있으며, 50.0 중량 ¾를 초과할 경우에는 함유량 증가에 따른 뚜렷한 미백 효과 증가가 없을 수 있으며 안전성 문제 또는 제형상의 제조에 어려움이 있을 수 있다.  In the present invention, the extract is characterized in that it is contained in 0.0001 to 50% by weight relative to the total composition. In the case of 0.0001% by weight or less of the range may not be a clear whitening effect, when it exceeds 50.0 by weight ¾ there may be no obvious whitening effect increase due to the increase of the content, there is a safety problem or difficulty in preparation of the formulation There may be.
본 발명에 있어서, 상기 조성물은 티로시나아제 (tyros inase) 활성 억제 및 멜라닌 생합성을 억제함으로써 피부 미백효과를 나타내는 것을 특징으로 한다. 본 발명의 실험예에 따르면, 본 발명의 무기환의 경우, 티로시나아제 저해 및 멜라닌의 형성을 억제하는 것을 확인할 수 있었으며, 더욱이 황련, 오수유 및 백작약 단독 추출물에 비해 티로시나아제 저해 효과에 있어서 더 뛰어난 것을 확인할 수 있었다. 이러한 결과로 볼 때, 본 발명의 무기환이 티로시나아제를 효과적으로 저해하고 멜라닌 생성 또한 효과적으로 억제함으로 피부 미백용 화장료 조성물로서 적합하다는 것을 알 수 있다 (실험예 1 내지 5 참조) . 본 발명에 있어서, 상기 조성물은 스킨로션, 스킨소프너, 스킨토너, 아스트린젠트, 로션, 밀크로션, 모이스쳐 로션, 영양로션, 맛사자크림, 영양크림, 모이스쳐 크림, 핸드크림, 파운데이션, 에센스, 영양에센스, 팩, 비누, 클렌징품, 클렌징로션, 클렌징크림, 바디로션 및 바디클렌저로 구성된 군으로부터 선택된 하나의 제형을 갖는 것을 특징으로 한다. In the present invention, the composition has a skin whitening effect by inhibiting tyrosinase activity and inhibiting melanin biosynthesis. According to the experimental example of the present invention, in the case of the inorganic ring of the present invention, it was confirmed that the inhibition of tyrosinase and the formation of melanin, and more excellent in the tyrosinase inhibitory effect than the extracts of sulfur, sesame and peony alone. I could confirm that. In view of these results, the inorganic ring of the present invention effectively inhibits tyrosinase and effectively inhibits melanin production. It can be seen that it is suitable as a cosmetic composition (see Experimental Examples 1 to 5). In the present invention, the composition is a skin lotion, skin softener, skin toner, astringent, lotion, milk lotion, moisturizing lotion, nutrition lotion, masseur cream, nutrition cream, moisture cream, hand cream, foundation, essence, nutrition essence, Pack, soap, cleansing product, cleansing lotion, cleansing cream, body lotion and body cleanser characterized in that it has one formulation selected from the group consisting of.
본 발명의 조성물은 담체 이외에 다른 보조제를 포함할 수 있는데, 예를 i:면 보존제, 항산화제, 안정화제 , 용해화제, 비타민, 안료 및 향료 등을 포함할 수 있다.  The composition of the present invention may include other auxiliaries in addition to the carrier, for example i: cotton preservatives, antioxidants, stabilizers, solubilizers, vitamins, pigments and flavorings and the like.
【유리한 효과】 Advantageous Effects
이상 설명한 바와 같이 본원발명의 무기환은 티로시나아제 저해 및 멜라닌의 형성을 억제함으로써 피부 미백효과를 나타내므로, 피부 미백용 천연 한방 화장료 조성물로서 적합하다.  As described above, the inorganic ring of the present invention exhibits a skin whitening effect by inhibiting tyrosinase inhibition and melanin formation, and thus is suitable as a natural herbal cosmetic composition for skin whitening.
【도면의 간단한 설명】 [Brief Description of Drawings]
도 1은 무기환의 멜라닌 생성 저해 효과의 결과를 나타내는 그래프이다. 도 2는 무기환의 세포 독성에 대한 결과를 나타내는 그래프이다.  1 is a graph showing the result of the melanin production inhibitory effect of the inorganic ring. Figure 2 is a graph showing the results for cytotoxicity of inorganic rings.
조 3은 무기환의 티로시나아제 유전자 발현에 대한 결과를 나타내는 그래프이다.  Figure 3 is a graph showing the results for the inorganic ring tyrosinase gene expression.
도 4는 무기환의 시너지 효과에 대한 결과로, 티로시나아제 저해 효과의 결과를 나타내는 그래프이다.  4 is a graph showing the results of the tyrosinase inhibitory effect as a result of the synergistic effect of the inorganic ring.
【발명의 실시를 위한 형태】 [Form for implementation of invention]
이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하기로 한다。 이들 실시예는 단지 본 발명을 예시하기 위한 것이므로, 본 발명의 범위가 이들 실시예에 의해 제한되는 것으로 해석되지는 않는다. 실시예 1 : 무기환 추출물의 제조 Hereinafter, the present invention will be described in more detail with reference to Examples. Since these Examples are only for illustrating the present invention, the scope of the present invention is not interpreted to be limited by these Examples. Example 1 Preparation of Inorganic Ring Extract
먼저 무기환 재료 황련, 오수유 및 백작약을 각각 동량으로 1: 1: 1의 비율로 담아 분쇄기에 넣고 lOOg의 흔합 분말을 제조한 후 증류수 1000 와 함께 약탕기에 넣고 열수 추출한다. 2~3시간 열수 추출 후 추출액을 와트만 (Waterman) 여과지로 감압 여과한 후, 건더기를 제거하고 나머지 추출액을 넁각콘덴서가 달린 감압 회전 증류장치에서 농축하여 건조중량 16.7g을 얻었다. 실험예 1 : 멜라노마 세포를 이용한 멜라닌 생성 저해 실험  First, the inorganic ring material, yellow rye, sewage oil, and white peony were added to a grinder in a ratio of 1: 1, respectively, to prepare a mixed powder of 100 g, and then put into a water bath with distilled water 1000 and extracted with hot water. After extracting the hot water for 2 to 3 hours, the extract was filtered under reduced pressure with a Waterman filter paper, and then, the remaining extract was concentrated in a vacuum rotary distillation apparatus with a condenser to obtain a dry weight of 16.7 g. Experimental Example 1: Melanin production inhibition experiment using melanoma cells
B16F10 쥐의 멜라노마 세포를 규정된 조건에서 배양하였다. 평가방법은 다음과 같다. 멜라노마 세포를 10% FBS를 포함하는 DMEM에 현탁시켜 wel l당 lxlO5 cel ls 으로 6-wel l pi ate에 접종하여 wel l 바닥에 부착 될 때까지 배양한다. 멜라닌 생성 유도를 위하여, O . luM a -MSH를 처리하고, 이후 시료를' 농도별로 첨가한 후 3일간 배양하였다. 무기환 추출물의 농도범위는 10/ig/i , 25/ g/ , 50/ig/m로 설정하였다. 멜라닌 생성능 실험의 양성대조군으로 알부틴 100/zg/m 을 처리하였다. 배양한 세포는 phosphate buffered sal ine(PBS)으로 씻고 트립신 (trypsin)으로 회수하였다. 회수한 세포를 혈구계 (hematocytometer )로 계수하여 각 처리 그룹별로 lxlO6 cel l s/mL 으로 동일한 세포수가 되도록 모아 lOOOrpm, 10분간 원심분리하여 세포만을 얻었다. 회수된 세포를 60°C에서 1시간 건조시켜 10% DMS0가 포함된 1M NaOH용액 을 넣어 세포내의 멜라닌을 얻었다. 이 멜라닌 액을 Microplate reader로 490nm에서 흡광도를 측정하여 멜라닌 생성 저해율을 평가하였다. Melanoma cells of B16F10 mice were cultured under defined conditions. The evaluation method is as follows. Melanoma cells were suspended in DMEM containing 10% FBS and inoculated in 6-wel l piate with lxlO 5 cel ls per wel l and incubated until adhered to the wel l bottom. To induce melanin production, O. luM a -MSH was treated, and then the samples were incubated for 3 days after the ' concentration was added. The concentration range of the inorganic ring extract was set to 10 / ig / i, 25 / g /, 50 / ig / m. Arbutin 100 / zg / m was treated as a positive control of the melanin production ability experiment. The cultured cells were washed with phosphate buffered salin (PBS) and recovered with trypsin. The recovered cells were counted by a hematocytometer and collected in each treatment group so as to have the same cell number as lxlO 6 cel ls / mL, followed by centrifugation for 10 minutes at 10 rpm to obtain only cells. The recovered cells were dried at 60 ° C. for 1 hour, and then 1M NaOH solution containing 10% DMS0 was added to obtain intracellular melanin. The melanin solution was measured for absorbance at 490 nm using a microplate reader to evaluate the inhibition of melanin production.
그 결과를 도 1에 나타내었다. 도 1에서 나타나는 바와 같이, 무기환 추출물에 의해 멜라닌 생성이 농도 의존적으로 감소함을 관찰하였다. 또한, 미백제로 알려진 알부틴보다 우수한 멜라닌 생성 저해 능력을 보였다. 그러므로, 본 실험을 통해 무기환 추출물이 미백 효능을 가지고 있음을 확인하였다. 실험예 2 : 세포독성 측정 실험  The results are shown in FIG. As shown in FIG. 1, it was observed that melanin production was reduced concentration-dependently by the inorganic ring extract. In addition, it showed melanin production inhibitory ability better than arbutin known as a whitening agent. Therefore, this experiment confirmed that the inorganic ring extract has a whitening effect. Experimental Example 2 Cytotoxicity Measurement Experiment
B16F10 쥐의 멜라노마 세포를 규정된 조건에서 배양하였다. 평가방법은 다음과 같다. 멜라노마 세포를 10% FBS를 포함하는 DMEM에 현탁시켜 wel l당 lxlO4 cells 으로 96-well plate에 접종하여 well 바닥에 부착 될 때까지 배양한다. 배지를 제거하고 0.1 /g/m£, 0.5 /g/i , 1 g/mi, 5 ug/mi, 10 fig/ id, 50 ug/ml 및 100 A 의 농도로 회석된 무기환 추출물을 배지에 처리하고, 5% C02 , 37°C하에서 24시간 배양하였다. 이후 세포독성 효과를 확인하기 위하여 DPBS에 녹인 MTT(3-(4,5-dimetylthiazol-2-yl)2,5-diphenyltetrazoliuni bromide)을 well당 씩 첨가하여 반웅시켰다. ΜΊΤ는 담황색의 기질로서 살아있는 세포의 미토콘드리아 내의 호흡연쇄효소에 의해 암청색으로 변한다. 4시간 후 반웅액을 버리고 DMS0를 넣어 변화된 색을 microplate reader로 570 nm에서 흡광도를 측정하였다. Melanoma cells of B16F10 mice were cultured under defined conditions. The evaluation method is as follows. Melanoma cells were suspended in DMEM containing 10% FBS per wel l Inoculate the 96-well plate with lxlO 4 cells and incubate until attached to the bottom of the well. Remove the medium, and add the inorganic ring extract distilled at concentrations of 0.1 / g / m £, 0.5 / g / i, 1 g / mi, 5 ug / mi, 10 fig / id, 50 ug / ml and 100 A Treated and incubated at 5% CO 2 , 37 ° C. for 24 hours. Afterwards, MTT (3- (4,5-dimetylthiazol-2-yl) 2,5-diphenyltetrazoliuni bromide) dissolved in DPBS was added to each well to confirm cytotoxic effects. ΜΊΤ is a pale yellow substrate that turns dark blue by respiratory chain enzymes in the mitochondria of living cells. After 4 hours, the reaction solution was discarded, and the absorbed color was measured at 570 nm using a microplate reader.
그 결과를 도 2에 나타내었다. 도 2에서 나타나는 바와 같이, 무기환 추출물에 의한 세포의 감소는 보이지 않는다. 그러므로, 본 실험을 통해 무기환 추출물은 세포독성이 없음을 확인하였다. 실험예 3: 티로시나아제 유전자 발현 확인 실험  The results are shown in FIG. As shown in Figure 2, there is no decrease in cells by the inorganic ring extract. Therefore, this experiment confirmed that the inorganic ring extract is not cytotoxic. Experimental Example 3: Tyrosinase gene expression confirmation experiment
B16F10 쥐의 멜라노마 세포를 규정된 조건에서 배양하였다. 평가방법은 다음과 같다. 멜라노마 세포를 10% FBS를 포함하는 DMEM에 현탁시켜 well당 lxlO5 cells 으로 6-well plate에 접종하여 well 바닥에 부착 될 때까지 배양한다. 멜라닌 생성 유도를 위하여, O.luM α-MSH를 처리하고, 이후 시료를. 농도별로 첨가한 후 24시간 배양하였다. 무기환 추출물의 농도는 0.1 ug/mi, 0.5 Mg/mi, 1 ug/ml, 5 ug/mi, 10 β /mi 및 50 g/i 의 농도로 희석된 무기환 추출물을 배지에 처리하였다. 양성대조군은 알부틴 100/g/i 을 처리하였다. 배양한 세포는 phosphate buffered saline으로 씻고 1 ra Trizol을 넣어 회수하였다. 0.2 Chloroform Triz 의 1/5 비율)을 넣어 voltexing 하여 4°C에서 14000 rpm, 15 분간 원심분리로 상층액을 얻었다. 동 상층액에 0.5 mt isopropanol 넣고 10분간 반웅시킨 후, 14000 rpm, 15 분간 원심분리하여 침전물을 얻었다. 상충액을 제거하고 200 fd 100% EtOH를 이용하여 2회 씻어준다. 이후 침전물을 상온에서 완전히 말려 DEPC water 20-30 ≠ 에 녹였다. DEPC에 녹인 RNA를 정량하여 각 그룹 당 RNA 동량을 사용하여 cDNA를 합성하였다. 합성된 cDNA를 타겟으로 시아닌 염료인 SYBR GREEN master mix 를 사용하여 실시간 중합효소 연쇄반웅 (PCR)을 실시하여 최종적으로 tyrosinase의 유전자 발현 정도를 평가하였다. 그 결과를 하기 표 1에 나타내었다. Melanoma cells of B16F10 mice were cultured under defined conditions. The evaluation method is as follows. Melanoma cells are suspended in DMEM containing 10% FBS and inoculated in 6-well plates with lxlO 5 cells per well and incubated until attached to the bottom of the well. To induce melanin production, treatment with O.luM α-MSH, and then take the sample. Incubated for 24 hours after addition by concentration. The concentration of the inorganic ring extract was treated with the inorganic ring extract diluted to 0.1 ug / mi, 0.5 Mg / mi, 1 ug / ml, 5 ug / mi, 10 β / mi and 50 g / i. Positive controls were treated with arbutin 100 / g / i. The cultured cells were washed with phosphate buffered saline and 1 ra trizol was collected. 1/5 ratio of 0.2 Chloroform Triz) was added and voltexed to obtain a supernatant by centrifugation at 14000 rpm for 15 minutes at 4 ° C. 0.5 mt isopropanol was added to the supernatant and reacted for 10 minutes, followed by centrifugation at 14000 rpm for 15 minutes to obtain a precipitate. Remove the supernatant and wash twice with 200 fd 100% EtOH. The precipitate was then completely dried at room temperature and dissolved in DEPC water 20-30 ≠. RNA dissolved in DEPC was quantified and cDNA was synthesized using the same amount of RNA per group. Using SYBR GREEN master mix, a cyanine dye, as a target for synthesized cDNA Real-time polymerase chain reaction (PCR) was performed to evaluate the gene expression level of tyrosinase. The results are shown in Table 1 below.
【표 1] [Table 1]
Figure imgf000010_0001
그 결과, 표 1에서 나타나는 바와 같이, a-MSH에 의해 유도되는 tyrosinase의 발현 증가에서 무기환 추출물에 의한 발현 억제를 확인할 수 있었다. 실험예 4: 티로시나아제 단백질 발현 확인 실험
Figure imgf000010_0001
As a result, as shown in Table 1, it was confirmed that the inhibition of the expression by the inorganic ring extract in the increased expression of tyrosinase induced by a-MSH. Experimental Example 4: Tyrosinase Protein Expression Confirmation Experiment
B16F10 쥐의 멜라노마 세포를 규정된 조건에서 배양하였다. 평가방법은 다음과 같다 멜라노마 세포를 10% FBS를 포함하는 DMEM에 현탁시켜 well당 lxlO5 cells 으로 6-well plate에 접종하여 well 바닥에 부착 될 때까자 배양한다. 멜라닌 생성 유도를 위하여, O.luM α-MSH를 처리하고, 이후 시료를 농도별로 첨가한 후 48시간 배양하였다. 무기환 추출물의 농도는 10 / 로 처리하였고, 양성대조군은 알부틴 100 //g/ 을 처리하였다. 배양한 세포는 phosphate buffered saline으로 씻고 100 ≠ RIPA lysis buffer를 넣어 회수하였다. 흔탁액을 voltexing하여 4°C에서 14000 rpm, 20 분간 원심분리하여 상층액을 얻었다. 상층액속의 단백질량을 브래드포드 에세이법으로 정량하여 각 그룹당 동량의 단백질을 사용하여 SDS-PAGE 전기영동을 실시하였다. PVDF membrane에 단백질 밴드를 전달하여 ECL용액으로 단백질의 발현량을 확인하였다. 그 결과를 도 3에 나타내었다. 도 3에서 나타나는 바와 같이, 무기환 추출물 처리에 의해 티로시나아제의 발현량이 감소하는 것을 확인하였다. 실험예 5: 무기환 및 각각 원료들의 티로시나아제 저해 확인 실험 Melanoma cells of B16F10 mice were cultured under defined conditions. The evaluation method is as follows culture was inoculated melanoma cells suspended in DMEM containing 10% FBS in 6-well plate with lxlO 5 cells per well kkaja when attached to the well bottom. To induce melanin production, O.luM α-MSH was treated, and then samples were incubated for 48 hours after the concentration was added. The concentration of the inorganic ring extract was treated with 10 /, and the positive control was treated with arbutin 100 // g /. The cultured cells were washed with phosphate buffered saline and collected in 100 ≠ RIPA lysis buffer. The suspension was voltexed and centrifuged at 14000 rpm for 20 minutes at 4 ° C to obtain a supernatant. The amount of protein in the supernatant was quantified by Bradford assay, and SDS-PAGE electrophoresis was performed using the same amount of protein for each group. PVDF The protein band was delivered to the membrane to confirm the expression level of the protein in the ECL solution. The results are shown in FIG. As shown in FIG. 3, it was confirmed that the expression amount of tyrosinase was reduced by the inorganic ring extract treatment. Experimental Example 5: Experiment for confirming tyrosinase inhibition of inorganic rings and respective raw materials
실험 방법은 <실험예 3>과 동일하다. 이 중 무기환 추출물의 농도는 1 /ig/ 로 처리하였고 그 구성 성분인 황금, 백작약 및 오수유도 각각 1 / g/i 의 농도로 처리하여 무기환의 미백효과에 대한 시너지 효과를 비교 하였다. 양성대조군은 알부틴 100 g/m£ 을 처리하였다. 그 결과를 표 2와 도 4에 나타내었다.  The experimental method is the same as that of <Experiment 3>. Among them, the concentration of the inorganic ring extract was treated with 1 / ig / and the synergistic effects of the whitening effect of the inorganic ring were compared by the concentrations of 1, g / i of gold, earl pear and sewage induction. Positive controls were treated with arbutin 100 g / m £. The results are shown in Table 2 and FIG.
【표 2】 Table 2
Figure imgf000011_0001
표 2 및 도 4에서 나타나는 바와 같이 3 가지 약재가 흔합된 무기환 추출물의 경우 각각의 단일 추출물보다 더 높은 티로시나아제 억제 효능을 나타내는 것을 볼 수 있다.
Figure imgf000011_0001
As shown in Table 2 and Figure 4 it can be seen that the three medicinal herbs mixed with a higher thyrosinase inhibitory effect than each single extract.

Claims

【청구의 범위】 [Range of request]
【청구항 1】 [Claim 1]
무기환을 유효성분으로 함유하는 피부 미백용 화장료 조성물.  Cosmetic composition for skin whitening containing an inorganic ring as an active ingredient.
【청구항 2】 [Claim 2]
제 1항에 있어서, 상기 무기환은 황련, 오수유 및 백작약의 추출물로 구성된 것을 특징으로 하는 피부 미백용 화장료 조성물.  The cosmetic composition for skin whitening according to claim 1, wherein the inorganic ring is composed of extracts of yellow lotus, sesame oil, and white peach.
【청구항 3】 [Claim 3]
제 2항에 있어서, 상기 추출물은 증류수, 탄소수 1 내지 4의 저급알코을, 부틸렌글리콜, 프로필렌글리콜, 글리세린 또는 이들의 흔합용매로 추출하는 것을 특징으로 하는 피부 미백용 화장료 조성물.  The cosmetic composition for skin whitening according to claim 2, wherein the extract is extracted with distilled water, lower alcohol having 1 to 4 carbon atoms, butylene glycol, propylene glycol, glycerin, or a mixed solvent thereof.
【청구항 4】 [Claim 4]
제 2항에 있어서, 상기 추출물은 총 조성물에 대하여 0.0001 내지 50.0 중량 %로 함유되는 것을 특징으로 하는 피부 미백용 화장료 조성물.  The cosmetic composition for skin whitening according to claim 2, wherein the extract is contained in an amount of 0.0001 to 50.0% by weight based on the total composition.
【청구항 5】 [Claim 5]
제 1항에 있어서, 상기 조성물은 티로시나아제 (tyrosinase) 활성 억제 및 멜라닌 생합성을 억제함으로써 피부 미백효과를 나타내는 것을 특징으로 하는 피부 미백용 화장료 조성물.  The cosmetic composition for skin whitening according to claim 1, wherein the composition exhibits skin whitening effect by inhibiting tyrosinase activity and inhibiting melanin biosynthesis.
【청구항 6】 [Claim 6]
제 1항에 있어서, 상기 조성물은 스킨로션, 스킨소프너, 스킨토너, 아스트린젠트, 로션, 밀크로션, 모이스쳐 로션, 영양로션, 맛사지크림, 영양크림 모이스쳐 크림, 핸드크림, 파운데이션 에센스, 영양에센스, 팩 , 비누, 클렌징품 클렌징로션, 클렌징크림, 바디로션 및 바디클렌저로 구성된 군으로부터 선택된 하나의 제형을 갖는 것을 특징으로 하는 미백용 화장료 조성물.  According to claim 1, wherein the composition is a skin lotion, skin softener, skin toner, astringent, lotion, milk lotion, moisturizing lotion, nutrition lotion, massage cream, nutrition cream moisturizer cream, hand cream, foundation essence, nutrition essence, pack, A whitening cosmetic composition comprising a soap, a cleansing product, a cleansing lotion, a cleansing cream, a body lotion, and a body cleanser.
PCT/KR2015/013618 2015-01-06 2015-12-11 Whitening cosmetic composition containing inorganic ring as active ingredient WO2016111478A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2015-0001150 2015-01-06
KR1020150001150A KR101791425B1 (en) 2015-01-06 2015-01-06 Cosmetic composition for skin-whitening comprising mixture extract of Coptis chinensis, EVODIA RUTAECARPA and Paeonia lactiflora P.

Publications (1)

Publication Number Publication Date
WO2016111478A1 true WO2016111478A1 (en) 2016-07-14

Family

ID=56356132

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2015/013618 WO2016111478A1 (en) 2015-01-06 2015-12-11 Whitening cosmetic composition containing inorganic ring as active ingredient

Country Status (2)

Country Link
KR (1) KR101791425B1 (en)
WO (1) WO2016111478A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010093860A (en) * 2001-08-29 2001-10-29 서경배 Whitening composition including the extract of the fruit of Evodia officinalis, E. rutaecarpa
KR20030026663A (en) * 2001-09-26 2003-04-03 코스맥스 주식회사 Whitening cosmetic composition containing herb extracts
KR100535875B1 (en) * 2004-07-02 2005-12-09 주식회사 생그린 Cosmetic composition comprising the extract of complex herb showing skin anti-aging and whitening effect
KR101081914B1 (en) * 2009-02-02 2011-11-09 한불화장품주식회사 Skin-care agent containing oriental-herb extracts
KR20110128385A (en) * 2010-05-23 2011-11-30 이경준 The herb medicine composition material and the manufacturing process for pimple skin-improvement uses by midam cheonggyeolan

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010093860A (en) * 2001-08-29 2001-10-29 서경배 Whitening composition including the extract of the fruit of Evodia officinalis, E. rutaecarpa
KR20030026663A (en) * 2001-09-26 2003-04-03 코스맥스 주식회사 Whitening cosmetic composition containing herb extracts
KR100535875B1 (en) * 2004-07-02 2005-12-09 주식회사 생그린 Cosmetic composition comprising the extract of complex herb showing skin anti-aging and whitening effect
KR101081914B1 (en) * 2009-02-02 2011-11-09 한불화장품주식회사 Skin-care agent containing oriental-herb extracts
KR20110128385A (en) * 2010-05-23 2011-11-30 이경준 The herb medicine composition material and the manufacturing process for pimple skin-improvement uses by midam cheonggyeolan

Also Published As

Publication number Publication date
KR101791425B1 (en) 2017-11-21
KR20160084900A (en) 2016-07-15

Similar Documents

Publication Publication Date Title
JP6411580B2 (en) Composition for suppressing sebum production, containing three white grass extracts
CN111093621A (en) Cosmetic composition containing dendrobium officinale flower extract
US8802167B2 (en) Use of Eclipta prostrata and other PPAR-gamma inhibitors in cosmetics and compositions thereof
KR20100088880A (en) Skin agent composition containing the oriental-herb extracts using microbial fermentation
KR100564108B1 (en) Cosmetic composition comprising plant extract having anti-aging effect
CN101336880A (en) Art pumpkin leaves extract and use in cosmetics
KR20170137553A (en) Composition for improving skin condition comprising herb extracts mixture
KR20170137564A (en) Composition for improving skin condition comprising herb extracts mixture
KR20170137549A (en) Composition for improving skin condition comprising herb extracts mixture
KR20070065925A (en) Skin whitening cosmetics composite containing oriental herb extract and manufacturing method thereof
KR102632084B1 (en) Cosmetic composition for anti-oxidation, skin whitening, and improving of skin wrinkle containing Sanguisorba officinalis extract
KR100515419B1 (en) Whitening cosmetics composition comprising natural herb extracts
KR20190038702A (en) Anti-inflammatory agent containing fermented laminaria japonica
WO2016111478A1 (en) Whitening cosmetic composition containing inorganic ring as active ingredient
CA2863591A1 (en) Use of starfruit extract as a cpt-1 modulator and compositions thereof
KR20090111679A (en) Whitening cosmetic composition including the extract of Astragali Radix
KR20170136930A (en) Composition for improving skin condition comprising herb extracts mixture
WO2011065699A2 (en) Method for extracting a traditional herbal medicine component using a polished-rice steaming method
KR20170137546A (en) Composition for improving skin condition comprising herb extracts mixture
KR20170136912A (en) Composition for improving skin condition comprising herb extracts mixture
KR101310655B1 (en) Cosmetic composition which contains trapa japonica flerov. extraction as active compotnets and the preparation method thereof
KR100931528B1 (en) Skin Whitening Composition Containing Radix Extract as Active Ingredient
CN110997074A (en) Topical compositions for anti-aging benefits
KR20190003012A (en) Use of hot water extract from Rehmannia glutinosa for the whitening cosmetics to prevent pigmentation
KR20170137556A (en) Composition for improving skin condition comprising herb extracts mixture

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15877198

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15877198

Country of ref document: EP

Kind code of ref document: A1